Late Cardiotoxicity from the Tyrosine Kinase Inhibitor, Dasatinib: Pleural Effusions, Pulmonary Arterial Hypertension, and Right Heart Failure

by Mark Jay Zucker, Andrew M. Zucker

2024 Volume 10, Issue 1, E20241012

application/pdf 307.0 kB
file_gsvxsxfaabcp7m75yabvox6xza digitalcommons.library.tmc.edu (publisher)
web.archive.org (webarchive)

Preserved and Accessible

Type article-journal
Stage

published

Date 2024-02-19
Language en ^?

DOI 10.58464/2378-2706.1062

Journal Metadata
Open Access Publication
In DOAJ
Not in Keepers Registry
ISSN-L: 2378-2706

Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)

Cite This

BibTeX
CSL-JSON
MLA
Harvard

Lookup Links

oaDOI/unpaywall (OA fulltext)
Crossref Metadata (via API)
Worldcat
SHERPA/RoMEO (journal policies)
wikidata.org
CORE.ac.uk
Semantic Scholar
Google Scholar

Catalog Record
Revision: 901ab917-37d2-4c25-98bc-6a958c36962c
API URL: JSON

Late Cardiotoxicity from the Tyrosine Kinase Inhibitor, Dasatinib: Pleural Effusions, Pulmonary Arterial Hypertension, and Right Heart Failure release_b3w3vtshzfeixec72kurcyrkum